Fennec PharmaceuticalsvsUnitedHealth

FENC and UNH stock compared: price, dividend, valuation and results, from SEC filings.

FENC

Fennec Pharmaceuticals Inc.

$13.45

Value $464M

-1.84%
FENC's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Fennec Pharmaceuticals (FENC) has a market value of $464M and UnitedHealth (UNH) $300B. Over the last year, with dividends, FENC moved +52.3% and UNH +12.1%. The P/E is 330.2 for FENC and 18.9 for UNH. Dividend yield: FENC none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FENC$464M

    UNH$300B

    UNH is 647 times FENC

  • Revenue, 12 months

    FENC$66M

    UNH$450B

    UNH is 6,775 times FENC

  • Net income, 12 months

    FENC$2.0M

    UNH$15.9B

    UNH is 7,832 times FENC

  • Operating margin

    FENC5.6%

    UNH5.3%

    0.3 points apart

  • ROIC

    FENC–

    UNH11.3%

  • P/E

    FENC330.2

    UNH18.9

    FENC is 17 times UNH

  • Dividend yield

    FENC0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    FENC+36.7%

    UNH-14.7%

    51.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FENC+36.7%

UNH-14.7%

5010015020222023202420252026
Returns by period
PeriodFENCWith dividendsUNHWith dividends
1 year since November 17, 2025+52.3%Price +52.3%+12.1%Price +9.2%
3 years since November 17, 2023+60.2%+17.0% a yearPrice +60.2%-30.5%-11.4% a yearPrice -34.8%
5 years since November 17, 2021+36.7%+6.5% a yearPrice +36.7%-14.7%-3.1% a yearPrice -22.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FENCFennec PharmaceuticalsUNHUnitedHealth

Valuation

FENCUNH
Valuation
Price$13.45$330.48
Market value$464M$300B
Enterprise value (EV)–$346B
P/E330.218.9
P/E, 5-year median–25.0
P/B9.42.9
EV/EBIT–14.5
Free cash flow yield0.7%7.6%

Results and growth

FENCUNH
Results and growth
Revenue, 12 months$66M$450B
Net income, 12 months$2.0M$15.9B
Free cash flow, 12 months$3.1M$22.8B
Earnings per share, 12 months$0.04$17.52
Revenue growth, year on year-6.1%11.8%
Revenue growth a year, past+204.7%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

FENCUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin5.6%5.3%
Net margin3.1%3.5%
ROIC–11.3%
ROE6.3%15.5%

Balance sheet

FENCUNH
Balance sheet
Cash$49M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover11.7×6.2×

Dividends and buybacks

FENCUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FENC or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Fennec Pharmaceuticals or UnitedHealth?

By market value, UnitedHealth ($300B) is about 646.9 times Fennec Pharmaceuticals ($464M), at today's prices.

How did FENC and UNH stock do over the last 5 years?

Since November 17, 2021, FENC's price moved +36.7% and UNH's -22.1%. With dividends: FENC +36.7% (+6.5% a year), UNH -14.7% (-3.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, FENC or UNH?

The dividend yield at today's price is none for Fennec Pharmaceuticals and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of FENC and UNH?

At today's price, the P/E is 330.2 for FENC and 18.9 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Fennec Pharmaceuticals or UnitedHealth?

Over the last twelve months, the net margin was 3.1% for Fennec Pharmaceuticals and 3.5% for UnitedHealth, and the operating margin 5.6% and 5.3%. Revenue was $66M and $450B.

Which is the better investment, Fennec Pharmaceuticals or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.